ATA421378A - Verfahren zum herstellen neuer carbostyrilderivate - Google Patents

Verfahren zum herstellen neuer carbostyrilderivate

Info

Publication number
ATA421378A
ATA421378A AT0421378A AT421378A ATA421378A AT A421378 A ATA421378 A AT A421378A AT 0421378 A AT0421378 A AT 0421378A AT 421378 A AT421378 A AT 421378A AT A421378 A ATA421378 A AT A421378A
Authority
AT
Austria
Prior art keywords
producing new
carbostyrile
derivatives
carbostyrile derivatives
producing
Prior art date
Application number
AT0421378A
Other languages
English (en)
Other versions
AT367038B (de
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP6931977A external-priority patent/JPS545981A/ja
Priority claimed from JP7586377A external-priority patent/JPS5412385A/ja
Priority claimed from JP53023012A external-priority patent/JPS6059912B2/ja
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Priority to AT6481A priority Critical patent/AT367039B/de
Publication of ATA421378A publication Critical patent/ATA421378A/de
Application granted granted Critical
Publication of AT367038B publication Critical patent/AT367038B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
AT0421378A 1977-06-10 1978-06-09 Verfahren zum herstellen neuer carbostyrilderivate AT367038B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT6481A AT367039B (de) 1977-06-10 1981-01-09 Verfahren zum herstellen neuer carbostyrilderivate

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP6931977A JPS545981A (en) 1977-06-10 1977-06-10 Carbostyryl derivatives
JP7586377A JPS5412385A (en) 1977-06-24 1977-06-24 Carbostyril derivative
JP53023012A JPS6059912B2 (ja) 1978-02-28 1978-02-28 カルボスチリル誘導体

Publications (2)

Publication Number Publication Date
ATA421378A true ATA421378A (de) 1981-10-15
AT367038B AT367038B (de) 1982-05-25

Family

ID=27284068

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0421378A AT367038B (de) 1977-06-10 1978-06-09 Verfahren zum herstellen neuer carbostyrilderivate

Country Status (21)

Country Link
US (1) US4298739A (de)
AR (2) AR224345A1 (de)
AT (1) AT367038B (de)
AU (1) AU510138B2 (de)
CA (1) CA1098907A (de)
CH (1) CH636087A5 (de)
DE (1) DE2825048A1 (de)
DK (1) DK149449C (de)
ES (2) ES470690A1 (de)
FI (1) FI69300C (de)
FR (1) FR2393795B1 (de)
GB (1) GB2002745B (de)
IE (1) IE46852B1 (de)
IT (1) IT1108326B (de)
MX (1) MX5527E (de)
NL (1) NL178074C (de)
NO (1) NO148813C (de)
NZ (1) NZ187452A (de)
PH (1) PH14670A (de)
PT (1) PT68157A (de)
SE (1) SE444562B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU843739A3 (ru) * 1978-02-17 1981-06-30 Карл Томэ Гмбх (Фирма) Способ получени карбостириловыхили ОКСиНдОлОВыХ пРОизВОдНыХ
AT383594B (de) * 1980-02-29 1987-07-27 Otsuka Pharma Co Ltd Verfahren zum herstellen von neuen carbostyrilderivaten und ihren salzen
JPS56122356A (en) * 1980-02-29 1981-09-25 Otsuka Pharmaceut Co Ltd Carbostyril derivative
FI77852C (fi) * 1981-02-17 1989-05-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av nya, saosom hjaertmediciner anvaendbara substituerade amid- och (maettad heterocykel)karbonylkarbostyrilderivat.
US4442111A (en) * 1981-07-25 1984-04-10 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Antithrombotic sulfimino and sulfoximino indolinones-2
US4578381A (en) * 1982-07-05 1986-03-25 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
CH655110A5 (de) * 1982-09-03 1986-03-27 Otsuka Pharma Co Ltd Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten.
US4663320A (en) * 1983-02-16 1987-05-05 Syntex (U.S.A.) Inc. (2-oxo-1,2,3,5-tetrahydroimidazo[2,1-b]quinoazolinyl)oxyalkylamides, compositions and the use thereof
US4490371A (en) * 1983-02-16 1984-12-25 Syntex (U.S.A.) Inc. N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides
IL74349A (en) * 1984-02-15 1988-07-31 Syntex Inc (2-oxo-1,2,3,5-tetrahydroimidazo(2,1-b)quinazolinyl)-oxyalkylamides,their preparation and pharmaceutical compositions containing them
US4670434A (en) * 1985-11-14 1987-06-02 Syntex (U.S.A.) Inc. (2-oxo-3-methylene-1,2,3,5-tetrahydroimidazo[2,1-b]quinazolinyl)oxyalkylamides useful as cyclic AMP phosphodiesterase inhibitors
JP2753622B2 (ja) 1988-05-02 1998-05-20 大塚製薬株式会社 カルボスチリル誘導体
US5227381A (en) * 1988-05-02 1993-07-13 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivative
TW201305B (de) * 1991-04-03 1993-03-01 Otsuka Pharma Co Ltd
KR930702307A (ko) * 1991-08-23 1993-09-08 오오쓰까 아끼히꼬 카르보스티릴 유도체 및 혈소판 응집 억제제
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
CA2628570A1 (en) 2005-11-09 2007-05-18 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
ES2393885T7 (es) 2007-06-04 2014-01-30 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
DE102008022221A1 (de) 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
EP2196453A1 (de) * 2008-12-10 2010-06-16 Cellvir Neuartige substituierte Aryl-Derivate, Herstellungsverfahren dafür und ihre therapeutische Verwendungen als anti-HIV-Mittel
CN102639512B (zh) 2009-08-21 2015-12-09 大塚制药株式会社 苯并[b][1,4]二氮杂*-2,4-二酮化合物的制备方法
TWI481601B (zh) 2009-08-21 2015-04-21 Otsuka Pharma Co Ltd 含氮化合物及藥學組成物
US8541404B2 (en) 2009-11-09 2013-09-24 Elexopharm Gmbh Inhibitors of the human aldosterone synthase CYP11B2
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
JP6251038B2 (ja) 2011-03-01 2017-12-20 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼcアゴニストの調製方法
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
AU2014218599C1 (en) 2013-02-25 2018-09-06 Bausch Health Ireland Limited Guanylate cyclase receptor agonists for use in colonic cleansing
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
US10011637B2 (en) 2013-06-05 2018-07-03 Synergy Pharmaceuticals, Inc. Ultra-pure agonists of guanylate cyclase C, method of making and using same
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス,インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス, インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR207554A1 (es) * 1972-12-02 1976-10-15 Otsuka Pharma Co Ltd Procedimiento para producir derivados de 3-alquil-5-((3,4-dihidro-5-carbostiril)oximetil)-oxazolidinona-(2)
JPS5239035B2 (de) * 1972-12-14 1977-10-03
JPS5234629B2 (de) * 1973-02-03 1977-09-05
SE431451B (sv) * 1973-10-24 1984-02-06 Otsuka Pharma Co Ltd Forfarande for framstellning av 2,3-dihydroxipropoxikinoliner eller -isokinoliner
US4022784A (en) * 1974-01-31 1977-05-10 Otsuka Pharmaceutical Company Limited 5-[1-Hydroxy-2-(substituted-amino)]alkyl-8-substituted-carbostyril and -3,4-dihydrocarbostyril derivatives
FI59246C (fi) * 1974-06-24 1981-07-10 Otsuka Pharma Co Ltd Foerfarande foer framstaellning av benscykloamidderivat anvaendbara vid trombos- och emboliterapin
JPS54119478A (en) * 1978-03-06 1979-09-17 Otsuka Pharmaceut Co Ltd Carbostyril derivative

Also Published As

Publication number Publication date
IT1108326B (it) 1985-12-09
PH14670A (en) 1981-10-30
IE46852B1 (en) 1983-10-05
NO148813B (no) 1983-09-12
GB2002745B (en) 1982-02-17
AR224345A1 (es) 1981-11-30
AU510138B2 (en) 1980-06-12
PT68157A (en) 1978-07-01
AU3686678A (en) 1979-12-13
GB2002745A (en) 1979-02-28
SE7806710L (sv) 1978-12-11
DE2825048C2 (de) 1991-05-08
ES479138A1 (es) 1979-07-01
NL178074C (nl) 1986-01-16
DK254878A (da) 1979-02-09
NO148813C (no) 1983-12-21
SE444562B (sv) 1986-04-21
AT367038B (de) 1982-05-25
IT7868355A0 (it) 1978-06-09
US4298739A (en) 1981-11-03
FR2393795A1 (fr) 1979-01-05
DK149449B (da) 1986-06-16
FR2393795B1 (fr) 1986-07-25
FI69300B (fi) 1985-09-30
IE781104L (en) 1978-12-10
NO782022L (no) 1978-12-12
NZ187452A (en) 1980-05-27
FI69300C (fi) 1986-01-10
CH636087A5 (de) 1983-05-13
FI781811A (fi) 1978-12-11
NL7806245A (nl) 1978-12-12
MX5527E (es) 1983-09-23
CA1098907A (en) 1981-04-07
DK149449C (da) 1986-11-24
DE2825048A1 (de) 1978-12-14
AR225755A1 (es) 1982-04-30
ES470690A1 (es) 1979-10-16

Similar Documents

Publication Publication Date Title
AT367038B (de) Verfahren zum herstellen neuer carbostyrilderivate
AT364363B (de) Verfahren zum herstellen neuer tetrazolylalkoxycarbostyrilderivate
DD134528A5 (de) Verfahren zum herstellen von schwefelhaltigen organosiliciumverbindungen
AT379345B (de) Verfahren zum herstellen von gipsplatten
AT359640B (de) Verfahren zum herstellen eines gammaglobulin- praeparates
AT375784B (de) Verfahren zum erzeugen magnetisierter bereiche
DD132129A5 (de) Verfahren zum herstellen von cellulosealkylaethern
AT376418B (de) Verrahren zum herstellen neuer phenylaethylaminderivate
ATA612278A (de) Verfahren zum herstellen von rollgebaeck
AT355101B (de) Verfahren zum herstellen eines leuchtschirmes
AT361921B (de) Verfahren zum herstellen von neuen chromen- derivaten
AT359491B (de) Verfahren zum herstellen neuer benzamidin- derivate
AT379547B (de) Verfahren zum herstellen von hohlkoerpern
AT359088B (de) Verfahren zum herstellen von auranofin
AT370535B (de) Verfahren zum herstellen eines originals
AT373591B (de) Verfahren zum herstellen neuer 1,3-benzoxazin-2,4-dion-derivate
AT362797B (de) Verfahren zum herstellen von auranofin
AT367039B (de) Verfahren zum herstellen neuer carbostyrilderivate
AT370709B (de) Verfahren zum herstellen eines neutronensicheren betons
ATA8080A (de) Verfahren zum herstellen neuer benzamidin- derivate
AT353564B (de) Verfahren zum herstellen eines feststoffge- misches
ATA394377A (de) Verfahren zum herstellen eines durchlassbau- werkes
AT361706B (de) Verfahren zum herstellen von olefinpoly- merisaten
ATA102880A (de) Verfahren zum herstellen eines kaeseartiger konsistenz
ATA784179A (de) Verfahren zum herstellen neuer chlorierter diraccheride

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee